GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Interest Expense

Sun Pharmaceuticals Industries (BOM:524715) Interest Expense : ₹-2,558 Mil (TTM As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sun Pharmaceuticals Industries's interest expense for the three months ended in Dec. 2024 was ₹ -515 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-2,558 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sun Pharmaceuticals Industries's Operating Income for the three months ended in Dec. 2024 was ₹ 35,618 Mil. Sun Pharmaceuticals Industries's Interest Expense for the three months ended in Dec. 2024 was ₹ -515 Mil. Sun Pharmaceuticals Industries's Interest Coverage for the quarter that ended in Dec. 2024 was 69.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharmaceuticals Industries Interest Expense Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Interest Expense Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,905.50 -1,410.90 -1,273.50 -1,720.00 -2,384.70

Sun Pharmaceuticals Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -347.30 -735.70 -615.40 -691.70 -515.10

Sun Pharmaceuticals Industries Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-2,558 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries  (BOM:524715) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharmaceuticals Industries's Interest Expense for the three months ended in Dec. 2024 was ₹-515 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹35,618 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Sun Pharmaceuticals Industries's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*35618.1/-515.1
=69.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sun Pharmaceuticals Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Interest Expense
Comparable Companies
NSE:DIVISLAB BOM:500087 NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 BOM:532321 NSE:AUROPHARMA BOM:500488 NSE:ALKEM ZTS XTER:MRK TSE:4502 LSE:HLN XSWX:GALD HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 TSE:4507
Traded in Other Exchanges
SUNPHARMA:India
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Website
https://www.sunpharma.com
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.

Sun Pharmaceuticals Industries Headlines

No Headlines